Cigna Group $CI Shares Bought by Capital World Investors

Capital World Investors boosted its position in shares of Cigna Group (NYSE:CI) by 0.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,336,112 shares of the health services provider’s stock after acquiring an additional 6,764 shares during the quarter. Capital World Investors’ holdings in Cigna Group were worth $367,738,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after buying an additional 414,834 shares during the period. Massachusetts Financial Services Co. MA increased its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the period. Dodge & Cox increased its position in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after buying an additional 354,615 shares during the period. Sanders Capital LLC increased its position in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after buying an additional 35,150 shares during the period. Finally, Geode Capital Management LLC increased its position in Cigna Group by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock worth $1,658,055,000 after buying an additional 48,474 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Up 0.1%

NYSE:CI opened at $289.71 on Tuesday. The firm has a market cap of $76.64 billion, a P/E ratio of 12.28, a PEG ratio of 1.12 and a beta of 0.28. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The stock’s 50 day simple moving average is $279.94 and its 200-day simple moving average is $277.41. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the previous year, the business earned $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Insider Buying and Selling at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on CI shares. Barclays lowered Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. TD Cowen boosted their target price on Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a report on Monday, February 9th. Wall Street Zen lowered Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Wells Fargo & Company boosted their target price on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.